NCT07437963 2026-03-18Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten WorseNational Cancer Institute (NCI)Phase 1/2 Not yet recruiting76 enrolled